EP3436463
CRYSTALLINE FORMS OF 2-[(2S)-1-AZABICYCLO[2.2.2]OCT-2-YL]-6-(3-METHYL-1H- PYRAZOL-4-YL)THIENO[3,2-D]PYRIMIDIN-4(3H)-ONE HEMIHYDRATE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
27.3.2017EP published:
23.6.2021EP application number:
17719053.5
EPO information:
European Patent Register
Max expiry date:
26.3.2037
Title:
CRYSTALLINE FORMS OF 2-[(2S)-1-AZABICYCLO[2.2.2]OCT-2-YL]-6-(3-METHYL-1H- PYRAZOL-4-YL)THIENO[3,2-D]PYRIMIDIN-4(3H)-ONE HEMIHYDRATE
Timeline
Today
27.3.2017EP application
23.6.2021EP Publication
Owner
Name:
Takeda Pharmaceutical Company LimitedAddress:
1-1 Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045, JP
Inventor
Name:
IWATA, KentaroAddress:
Fujisawa Kanagawa 251-0012, JP
Name:
MIZUNO, MasahiroAddress:
Yodogawa-ku Osaka-shi 532-0024, JP
Name:
MAEDA, KazuhiroAddress:
Yodogawa-ku Osaka-shi 532-0024, JP
Name:
YASUMA, TsuneoAddress:
Yodogawa-ku Osaka-shi 532-0024, JP
Name:
HOMMA, MisakiAddress:
Fujisawa 251-0012, JP
Name:
OGURO, YuyaAddress:
Fujisawa 251-0012, JP
Name:
TAYA, NaohiroAddress:
Fujisawa 251-0012, JP
Name:
ZHU, LeiAddress:
Bedford, MA 01730, US
Name:
BAILEY, John, DanielAddress:
Boston, MA 02128, US
Name:
LANGSTON, MarianneAddress:
Cambridge, MA 02139, US
Name:
PATIL, Siddhesh, DinanathAddress:
Cambridge, MA 02138, US
Name:
GOUR, ShrutiAddress:
Watertown, MA 02472, US
Name:
ROY, LillyAddress:
Boston, MA 02108, US
Priority
Number:
201662314080 PDate:
28.3.2016Country:
US
Number:
201662367842 PDate:
28.7.2016Country:
US
Classification
Categories:
C07D 495/04, A61P 35/00, A61P 35/02, A61P 43/00